前收市價 | 32.96 |
開市 | 33.08 |
買盤 | 32.90 x 51100 |
賣出價 | 33.00 x 25600 |
今日波幅 | 32.84 - 33.27 |
52 週波幅 | 21.14 - 35.30 |
成交量 | |
平均成交量 | 2,307,477 |
市值 | 49.066B |
Beta 值 (5 年,每月) | 0.67 |
市盈率 (最近 12 個月) | 33.24 |
每股盈利 (最近 12 個月) | 0.99 |
業績公佈日 | 2024年8月01日 - 2024年8月05日 |
遠期股息及收益率 | 0.30 (0.90%) |
除息日 | 2024年5月08日 |
1 年預測目標價 | 35.24 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.